Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonsurf Plus Chemotherapy in Metastatic Colorectal Cancer
NCT06495463Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Mar 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of trifluridine + tipiracil in colorectal cancer (CRC), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Disease control rate at 24 months. Started Mar 2022; status: completed.
02
Drugs
trifluridine + tipiracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06495463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06495463.